Clinical Cancer Drugs
Title:Acknowledgements to Reviewers:
Volume: 2
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Clinical Cancer Drugs 2015; 2 (2) . https://dx.doi.org/10.2174/2212697X0202151126114418
DOI https://dx.doi.org/10.2174/2212697X0202151126114418 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Current Drug Targets Hypertension and Angiogenesis
Current Pharmaceutical Design Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds
Medicinal Chemistry Characterization of Seven New Polystyrene Plates Binding Peptides from a Phage-Displayed Random 12-Peptide Library
Combinatorial Chemistry & High Throughput Screening Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Current Drug Therapy Innate Immunity and Vaccines
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Cancer Drug Targets Excisional Haemorrhoidectomy: Where Are We?
Reviews on Recent Clinical Trials Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity
Current Pharmaceutical Biotechnology Understanding FOXO, New Views on Old Transcription Factors
Current Cancer Drug Targets Therapeutic Potentials of Recently Identified PLD Inhibitors
Current Chemical Biology Photodynamic Inactivation of Yeast and Bacteria by Extracts of Alternanthera brasiliana
Current Drug Targets ADAM-Integrin Interactions: Potential Integrin Regulated Ectodomain Shedding Activity
Current Pharmaceutical Design The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum
Current Neuropharmacology Current Innovations in Laparoscopy
Current Women`s Health Reviews Deregulation of the Akt Pathway in Human Cancer
Current Cancer Drug Targets ADAM9 as a Potential Target Molecule in Cancer
Current Pharmaceutical Design Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry Glycomics: Relevance for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine YB-1 Protein and Multidrug Resistance of Tumor Cells
Current Signal Transduction Therapy